Company Information:
Jun 05, 2003 | Mr. Cunningham qualifies as an "independent director" under the NYSE rules and as an "audit committee financial expert" under the recently issued rules of the Securities Exchange Commission.
Feb 03, 2003 | To Support Development Efforts for a Next-generation Medical Device
Feb 28, 2002 |